Intellectual Property India Publishes Patent Application for 'An Alternative Process For (3r)-7-[[4-Cyclopentyl-3-(Trifluoromethyl)Phenyl]Methoxy]-1,2,3,4-Tetra Hydrocyclopent [B]Indole-3-Acetate Larginine And Intermediates Thereof' Filed by Maithri Drugs Private Limited

MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202441011147 A) filed by Maithri Drugs Private Limited, Hyderabad, Telangana, on Feb. 17, 2024, for 'an alternative process for (3r)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetra hydrocyclopent [b]indole-3-acetate larginine and intermediates thereof.'

Inventor(s) include Chakilam Nagaraju; Achampeta Kodanda Ramprasad; Rebelli Pradeep; and Nageshwar Rao Penumati.

The application for the patent was published on Sept. 5, under issue no. 36/2025.

According to the abstract released by the Intellectual Property India: "An alternative process for (3R)-7-[[4-cyclopentyl-3-(trifluoro methyl) phenyl] methoxy]-1,2,3,4- tetra hydrocyclopent [b]indole-3-acetate, L-Arginine and intermediates thereof. 10 The present application relates to an alternative process for Etrasimod L-Arginine and intermediates thereof, is represented by the following structural formula-I."

Disclaimer: Curated by HT Syndication.